Back to
Aptus Capital Advisors, LLC
GILD25 quarters
Position history for
Aptus Capital Advisors, LLC's holdings in GILEAD SCIENCES INC
Yes. Aptus Capital Advisors holds 74,929 shares of GILD (Gilead Sciences), worth $9.5M, as of its Q2 2026 13F filing. It reduced the position by 451 shares (-0.6%) from Q1 2026. Aptus Capital Advisors has held GILD since Q3 2022, across 16 quarterly 13F filings. GILD is 0.1% of Aptus Capital Advisors' reported 13F portfolio.
Current Value
$9.5M
Current Shares
74,929
Total Value Change
+$7.4M
Total Shares Change
+43,377
Quarter-by-Quarter History
Other major holders of GILD: BlackRock, Inc., VANGUARD GROUP INC